Human Umbilical Cord MSC-Derived Exosomes Suppress the Development of CCl4-Induced Liver Injury through Antioxidant Effect

Abstract EN

Mesenchymal stem cells (MSCs) have been increasingly applied into clinical therapy.

Exosomes are small (30–100 nm in diameter) membrane vesicles released by different cell types and possess the similar functions with their derived cells.

Human umbilical cord MSC-derived exosomes (hucMSC-Ex) play important roles in liver repair.

However, the effects and mechanisms of hucMSC-Ex on liver injury development remain elusive.

Mouse models of acute and chronic liver injury and liver tumor were induced by carbon tetrachloride (CCl4) injection, followed by administration of hucMSC-Ex via the tail vein.

Alleviation of liver injury by hucMSC-Ex was determined.

We further explored the production of oxidative stress and apoptosis in the development of liver injury and compared the antioxidant effects of hucMSC-Ex with frequently used hepatic protectant, bifendate (DDB) in liver injury.

hucMSC-Ex alleviated CCl4-induced acute liver injury and liver fibrosis and restrained the growth of liver tumors.

Decreased oxidative stress and apoptosis were found in hucMSC-Ex-treated mouse models and liver cells.

Compared to bifendate (DDB) treatment, hucMSC-Ex presented more distinct antioxidant and hepatoprotective effects.

hucMSC-Ex may suppress CCl4-induced liver injury development via antioxidant potentials and could be a more effective antioxidant than DDB in CCl4-induced liver tumor development.